Reset Health and Pharmacy2U form strategic partnership to transform the delivery of obesity treatment and care in the UK

• The strategic partnership brings together Reset Health's expert clinician-led approach with Pharmacy2U, the UK’s largest online pharmacy.
• This partnership provides the bedrock for a long-term transformational collaboration to deliver end-to-end treatment and care for the growing population using GLP-1 medications.
• Growing scientific evidence¹ supports the notion that in addition to weight loss medications, people living with obesity require further wraparound support for optimal health outcomes.
• The strategic partnership launches in Q1 2026, delivering GLP-1s direct to patients combined with integrated clinical wraparound care.

‍

18 February 2026 London, UK.

Reset Health, the experts in the personalised management of chronic disease, has entered a strategic partnership with Pharmacy2U, the UK’s largest online pharmacy, to deliver next-generation digital weight management support to patients using weight loss medication across the UK. This strategic partnership provides the foundation for a long-term transformational collaboration in the UK obesity market, delivering end-to-end treatment and care for the growing population using GLP-1 medications.

The collaboration launches in the first quarter of 2026 with Pharmacy2U patients receiving Reset Health’s digitally delivered wraparound care alongside their weight management treatment, combining medication with continuous clinical support for better engagement, experience and sustained outcomes. The partnership will see delivery of GLP-1s direct to patients across the UK while providing the clinical wraparound care essential for sustained results.

Oliver McGuinness, CEO of Reset Health said: “GLP-1s can transform the health of the nation, but we founded Reset Health because we knew treating chronic conditions requires more than medication alone. It needs continuous clinical support that is tailored to the needs of patients. This strategic partnership with Pharmacy2U is the foundation of how together we will transform obesity treatment in the UK. By combining rapid GLP-1 access with expert clinical wraparound care, we can help patients achieve sustained health benefits and behaviour change that meaningfully enables them in their everyday life.”

Recent studies, such as by Oxford's Nuffield Department of Primary Care Health Sciences¹, have shown that patients coming off GLP-1 medications regain weight more rapidly than after dietary interventions alone, in many cases exceeding their original weight. This highlights the need to ensure eligible patients are appropriately retained on GLP-1 medications longer term, with clinical oversight, to ensure they receive wider health benefits and prevent weight fluctuations. Medication licensing also demands that GLP-1 medication for obesity must be delivered alongside dietary, psychological and behavioural support, whilst increasing physical activity, for the best long-term outcomes.

Kevin Heath, CEO of Pharmacy2U said: “We’re at a pivotal moment for the obesity management industry, marked by growing interest in GLP-1 treatments that pair medication with longer-term behavioural and clinical support. Together with Reset Health, we’re excited to be pioneering a new digitally-driven approach to medicated weight loss that aims to put control back in the hands of patients.”

Oliver McGuinness, CEO of Reset Health added, “The sales of obesity medicines are rapidly changing with the advent of new policies in how treatments are getting to patients under the US administration. This model has the potential to streamline the delivery of medication and if successful, with cost and efficiency pressures on healthcare systems around the world, this could be replicated in other international medication dispensation markets.”
‍

Every patient receiving treatment will be able to access medication rapidly through the UK's largest online pharmacy, with one-click repeat prescription ordering through the digital platform alongside being directed to access to expert clinical support at the same time. Participants will receive support on their weight-loss journey via Reset Health’s clinical team on its digital health platform, which includes monthly consultations, evidence-based coaching and nutrition support, with access to health coaches, dietitians, and ongoing psychological support.
‍

The strategic partnership between Reset Health and Pharmacy2U aims to increase the focus of weight loss programmes on achieving long-term sustainable weight-loss. Without ongoing clinical support and lifestyle interventions, sustained weight loss remains challenging to achieve. Over the course of this partnership, data will be continuously gathered. The evaluations will add to a growing body of clinical evidence demonstrating that taking a holistic approach to weight management delivers long-lasting outcomes for patients.

ENDS

For media enquiries, contact‍

Matthew Neal (+44 7917 800 011) 
Charlotte Dawson (+447810 406 284)
resethealth@5654.co.uk

Pharmacy2U‍

Nick Albrow (+447834 827 870)
Pharmacy2u@theacademypr.com

Notes to Editors

1. https://www.ox.ac.uk/news/2026-01-08-new-study-finds-stopping-weight-loss-drugs-linked-faster-regain-ending-diet

About Reset Health

Reset Health (www.resethealth.clinic) is a digital health company delivering end-to-end management of chronic conditions by combining its Reset Technology Platform (RTP), with the latest innovative evidence-based clinical care pathways for each chronic condition it treats. Reset’s integrated care model for metabolic health, Roczen (www.roczen.com), is used in conjunction with new anti-obesity medications, GLP-1s and GIPs, to enhance health outcomes of patients with obesity and associated co-morbidities.

Reset Health is regulated by the Care Quality Commission and recommended by the National Institute of Clinical Excellence (NICE) on a time-limited basis as further evidence is generated. Reset Health provides care across the UK, Europe and Malaysia where its integrated care models are available to millions of patients, working with pharma, governments, employers, insurers, private providers and health systems.

www.resethealth.clinic

About Pharmacy2U

Pharmacy2U is the UK’s largest digital healthcare platform, serving over 1.8 million patients by putting them in control of their healthcare. Its mission is to enable accessible, exceptional healthcare
whenever and wherever people need it.   

Founded in 1999, and a trusted NHS partner since 2001, Pharmacy2U has revolutionised the repeat prescription industry and evolved into the ultimate digital healthcare provider, prioritising excellence at every turn. Based in Leeds, Leicestershire and London, it is a multi-award-winning business, with patient care and nurture at the forefront, supported by 600,000+ Trustpilot reviews and excellent
ratings.

Pharmacy2U’s digital healthcare platform offers a wide range of purposeful products and services online and via its app including:

• Free fully tracked delivery of NHS prescriptions
• Family accounts to manage prescriptions for those you care for 
• Access to NHS services including Pharmacy First and the Pharmacy Contraception Service 
• Online Doctor consultations for 11 conditions including sexual health, weight loss and skin problems 
• Over 2,500 low-cost vet medication and pet products
• Medicine stock checker providing patients with real-time updates on prescription availability
• Health & Wellness shop with 4000+ great value products and bundles 
• Health Hub and NHS tools for health advice on the go 
• Access to additional advice via virtual app live chat and customer services, plus personalised
  pharmacist recommendations   

A trusted member of the Company Chemists’ Association (CCA), Pharmacy2U is empowered by innovative technologies to constantly improve healthcare access for its customers, so they have control of their healthcare. In 2022, the business appointed CEO Kevin Heath to drive forward its ambitious vision to become a world-leading digital healthcare platform.

www.pharmacy2u.co.uk